Clinical Trials Directory

Trials / Completed

CompletedNCT06199050

The Effect of 360° Virtual Reality Movies on Fear and Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
292 (actual)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the effect of web-based 360° Virtual Reality movies on fear and anxiety, The investigators would like to assess the patient-perceived level of fear and anxiety quantitatively, making use of several questionnaires.

Detailed description

In ENGAGE, a KWF Samenloop Voor Hoop subsidized project, we have developed VR movies to reduce fear and anxiety for patients who are going to be treated at Maastro. These movies are based on where most fear and anxiety are experienced and have been developed after extensive discussion with different disciplines in patient care and with agreement of the Director Patient Care. The movies include: 1) Mouldroom, 2) VMDIBH mamma photons, 3) Head and Neck photons, 4) Lung photons, 5) CT-scan, 6) Prostate photons, and 7) Head and Neck/ Neuro protons. Currently, the web-based 360° movies are implemented in clinical practice and the VR glasses with the 360° movies will be used as soon as social work has decided on where to integrate the use in the care pathway.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire: SPIRITT0: Before the first intake at Maastro, the Trialpoli (TP) contacts a patient via phone to inform whether or not he is interested in participating in this study. If the patient shows interest in participating in the study, he will be invited for a consultation with the Trialpoli. This consultation takes place on the day of intake at Maastro. After consent, the patient is randomized to fill out T0 before or after the intake. T1: After filling out T0, the patient receives the ENGAGE information card with the url en QR code to the VR-movie. After watching the VR movie and before start RT the patient is asked to fill in T1. This questionnaire is distributed with instructions by the TP. T2: Between the 5th and the 15th radiation treatment, patients will be asked to fill in the questionnaires for the third and last time. The Patient Information Form (PIF) and Informed Consent (IC) are added in a separate document.
OTHERQuestionnaire: HADSHospital Anxiety and Depression Scale, 14 questions likert scale
OTHERQuestionnaire: QSC-R23Dutch version of the Questionnaire on stress symptoms, 23 questions likert scale
OTHERGeneral questions* Education level * Marietal status * Medication use (in order to assess influence on fear) * Previous cancer diagnosis * Acquired information on treatment * Expected fear and anxiety mitigation strategies * Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) * PROM at baseline
OTHERClinical data collectedClinical data in HIX: * Age * Gender * Cancer type * WHO status * TNM

Timeline

Start date
2023-06-16
Primary completion
2025-05-13
Completion
2025-05-13
First posted
2024-01-10
Last updated
2025-10-02

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06199050. Inclusion in this directory is not an endorsement.